The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed.
Irving Investors is a growth fund with a sector agnostic approach.
Venture capitalDenver, CO, USAirvinginvestors.comRounds from 2021-11-03 to 2026-09-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nscale Nscale full-stack AI cloud platform and services are designed for scale, resilience, and speed. | Convertible Verified against 1 of 17 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.4B | 2026-09-25 | [ PART ] |
Series G Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $196.5M |
| 2022-12-13 |
| [ PART ] |
Model Medicines, Inc. Model Medicines, Inc. sells AI-driven biotechnology solutions focused on developing first-in-class small molecules targeting biological choke points in diseases. | Funding round Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $4.1M | 2021-11-03 | [ PART ] |